For the first time ever, a new study conducted by Oxford Economics examines the broad economic impact the gaming industry as a whole has on the U.S. economy. The American Gaming Association released the first-of-its-kind study, which measures the economic impact of every facet of the casino gaming industry–commercial casinos and manufacturers and Native American casinos–as well as the industry’s significant ripple effect on the supply chain, including local businesses.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7338051-american-gaming-association-releases-oxford-economics-gaming-industry-impact-study/
Evidence from the Childhood Cancer Survivor Study suggests that changes in childhood cancer treatment have reduced deaths from the late effects of cancer treatment and extended the lives of childhood cancer survivors. St. Jude Children’s Research Hospital investigators led the research, which will be presented today at the plenary session of the 2015 annual meeting of the American Society of Clinical Oncology (ASCO).
The study is one of four being featured at the plenary session press briefing, which highlights research that ASCO deems as having the highest scientific merit and greatest potential to affect patient care.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7532851-st-jude-cancer-research/
Do you want to live a kingdom driven life? Do you want to discover your divine purpose? Do you want to discover the life you were born to live and ignite it with passion?
The kingdom driven life by Pastor Sunday Adelaja is a book that will help you to do just that. You may have been battling with questions like, what on earth am I here for?
What is the purpose of life? Matthew 6:33, Jesus instructs us to seek first the Kingdom. Seeking the kingdom of God should be our priority.
If we are going to make a significant impact on the earth, possess and disciple nations; we need to understand the precepts and principles of the kingdom.
Pastor Sunday Adelaja’s book will help you discover God’s priority for mankind, your original purpose for existence, and the source of meaning behind life.
You will be equipped with the tools, and strategies for promoting and expanding the Kingdom.
Many admit that this book is one of the top 3 books written in the last 1000 years.
To get your own copy, click here: http://this-productrocks.com/KingdomDrivenLife
Tags:
the kingdom driven life, kingdom driven life, purpose driven life, purpose of life, the purpose driven life, the purpose of life, purpose in life, what is the purpose of life, keys to the kingdom, seek first the kingdom of god, kingdom of god, evangelism, spiritual awakening, spiritual disciplines, personal growth, holy spirit, the holy spirit, spiritual gifts, word of faith, word of god, christian, christian books, spirituality, gospel, jesus, church, christianity, bible study, god, bible verses, prayer, prayers, daily devotions, discipleship, what is the kingdom of god, church leaders, spiritual leadership, church growth, kindle, kindle books, kindle book
Data presented today at the World Diabetes Congress of the International Diabetes Federation (IDF) show that adults with type 2 diabetes achieved improved glycaemic control, significantly lower rates of overall and nocturnal confirmed hypoglycaemia for the full trial period, and a significantly lower rate of severe hypoglycaemia during the maintenance period (defined as week 16 onwards) with Ryzodeg® compared to biphasic insulin aspart 30, both administered twice-daily1.
Ryzodeg® is the first combination of two distinct insulin analogues, Tresiba® (insulin degludec), the once-daily basal insulin with an ultra-long duration of action, and the well-established mealtime insulin NovoRapid® (insulin aspart), in the ratio of 70% and 30%, in one pen for people with type 2 diabetes2-4.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/64158-ryzodeg-improved-glycaemic-control
Today, Novo Nordisk announced new phase 3 interim data from its guardianTM2 trial for its recombinant coagulation factor VIII (rFVIII) product NovoEight® (turoctocog alfa), the first new rFVIII molecule in over a decade, which shows that it provides long-term reduction from bleeding in people with haemophilia A when used as a preventative treatment.1 The results were presented at the World Federation of Haemophilia (WFH) World Congress and support findings from other studies within the guardianTM clinical programme that found NovoEight® demonstrated good efficacy in preventing and treating bleeds without inhibitor development in previously treated patients.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/71400529-novoeight-reduction-of-bleeding-haemophilia-a
International research led by University College London (UCL) as part of the ‘Cities Changing Diabetes’ partnership programme challenges current scientific understanding of the rapid rise of diabetes in cities. The findings suggest that in cities around the world, social and cultural factors play a far more important role in the spread of the epidemic than previously thought.
More than two thirds of the world’s 400 million people with diabetes live in urban areas.1,2 The year-long study for Cities Changing Diabetes, a unique public-private-academic partnership, sought to better understand what makes people vulnerable to type 2 diabetes in cities in order to inform solutions for one of the most pressing modern-day public health challenges. To explore this complex issue, more than 550 interviews were undertaken with at-risk and diagnosed people in five major cities – Copenhagen, Houston, Mexico City, Shanghai and Tianjin.
“By largely focusing on biomedical risk factors for diabetes, traditional research has not adequately accounted for the impact of social and cultural drivers of disease,” says David Napier, Professor of Medical Anthropology, UCL. “Our pioneering research will enable cities worldwide to help populations adapt to lifestyles that make them less vulnerable to diabetes.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7690951-study-rethink-rise-diabetes-in-cities/
During the Academy of Nutrition and Dietetics 2017 Food & Nutrition Conference & Expo™ in Chicago, scientists reported on a recent study which uncovered that the intake of pistachios reduces the rise in blood sugar and insulin in women diagnosed with gestational diabetes mellitus (GDM)—commonly known as gestational diabetes. The study, “Effects of Pistachio Intake on Postprandial Blood Glucose Response in Pregnant Women,” found when women who were gestational glucose intolerant (GIGT) or who were diagnosed with GDM ate pistachios, they had a significantly lower rise in blood glucose levels compared to eating whole wheat bread that was matched for calories.
To view the multimedia release go to:
https://www.multivu.com/players/English/8162751-american-pistachio-growers-pistachio-health-benefits-women-gestational-diabetes/
Algebra has often been referred to as the “gateway” course with research showing the positive correlation between the early mastering of algebra and college graduation and employment income.
Kumon, the world’s largest after-school math and reading program, understands the importance of advanced study and discovering the true potential of children. As a learning program based on ability rather than age or grade, it is common to see children in Kumon Centers studying math and/or reading material two to three years above their school grade level.
To view the multimedia release go to:
https://www.multivu.com/players/English/7970151-kumon-inaugural-student-conference-disney/
Centennial College's Heavy Duty Equipment Technician is a two-year program in which students spend the first eight months in school, eight months in co-op as a registered apprentice and a final eight months in school. As part of the in-school curriculum, students train on heavy duty equipment assemblies in fully-equipped heavy duty equipment labs.
Kohler raises the bar on toilet flushing platforms with the launch of its new Revolution 360 swirl flush technology. The brands extensive experience in the toilet industry supports its understanding that critical drivers of owner satisfaction are toilet cleanliness and flush performance – both addressed in the new platform.
Revolution 360 is Kohler’s most complete flush ever developed and is powered by the brand’s widely popular AquaPiston canister technology which allows water to flow out of the tank at 360 degrees, increasing the power and effectiveness of the flush. Once out of the tank the water flows into the bowl from a single, powerful port and swirls throughout the bowl. Utilizing this swirling motion, Revolution 360 keeps the bowl cleaner, longer than a conventional flush. Kohler’s team of engineers engaged experiment and Computational Fluid Dynamics methods to study, improve and perfect even the smallest details to ensure complete rinsing of the entire bowl surface.
To view the multimedia release go to:
https://www.multivu.com/players/English/8176751-kohler-revolution-360-toilet-flushing-platform/
More than 15 percent of reproductive-aged women have filled a prescription for an antidepressant medication during the years 2008–2013, according to a new analysis published today in the Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report (MMWR).
January is National Birth Defects Prevention Month and the CDC is working with the March of Dimes to raise awareness about the use of antidepressant medications by women of reproductive age, and what women should know and do for their own health and that of their babies. There is conflicting evidence about the potential link between some antidepressants and certain birth defects. Some commonly used antidepressants are sertraline (Zoloft), bupropion (Wellbutrin, Zyban), and citalopram (Celexa).
To view the multimedia release go to:
http://www.multivu.com/players/English/7709851-march-of-dimes-antidepressant-pregnancy-study/
Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale (PFO) can prevent recurrent ischemic strokes, W. L. Gore & Associates, Inc. (Gore) has received approval from the U.S. Food and Drug Administration (FDA) for an expanded indication for its GORE® CARDIOFORM Septal Occluder. The device, already approved for closure of atrial septal defects (ASDs) up to 17 mm, is now also approved for the closure of PFO to reduce the risk of recurrent ischemic stroke in certain patients.*
To view the multimedia release go to:
https://www.multivu.com/players/English/8301551-gore-cardioform-septal-occluder-fda-approval/
